Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the EBMT ⁦@BMTjournal⁩

Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma | Bone Marrow Transplantation

Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

Rates and predictors of infusion-related reactions in patients receiving standard versus prolonged infusion of rabbit anti-thymocyte globulin for hematopoietic stem cell transplantation, a retrospective analysis | Bone Marrow Transplantation

Addition and drug monitoring of mycophenolate mofetil for GVHD prophylaxis in unrelated bone marrow transplantation | Bone Marrow Transplantation

CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis | Bone Marrow Transplantation

Low-dose unfractionated heparin prophylaxis is a safe strategy for the prevention of hepatic sinusoidal obstruction syndrome after myeloablative adult allogenic stem cell transplant | Bone Marrow Transplantation

Neutralizing antibody and T cell responses to SARS-CoV-2 vaccination in hematopoietic cell transplant recipients | Bone Marrow Transplantation

Comparative analysis of Decitabine intensified BUCY2 and BUCY2 conditioning regimen for high-risk MDS patients undergoing allogeneic hematopoietic stem cell transplantation | Bone Marrow Transplantation

Endothelial complications after allogeneic stem cell transplantation in patients with pretransplant resolved COVID-19 | Bone Marrow Transplantation

Safety and feasibility of outpatient chimeric antigen receptor (CAR) T-cell therapy: experience from a tertiary care center | Bone Marrow Transplantation

Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01 | Bone Marrow Transplantation #bmtsm

Autologous stem cell transplantation for multiple myeloma patients with chronic kidney disease: a safe and effective option | Bone Marrow Transplantation @bmtsm

Impact of maintenance therapy post autologous stem cell transplantation for multiple myeloma in early and delayed transplant | Bone Marrow Transplantation

The impact of HLA donor-specific antibodies on engraftment and the evolving desensitization strategies | Bone Marrow Transplantation

Haemophagocytic lymphohistiocytosis following allogeneic hematopoietic cell transplantation from mismatched unrelated donors associated with low CD34 and CD3 cell counts in the graft | Bone Marrow Transplantation

Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy | Bone Marrow Transplantation

Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma | Bone Marrow Transplantation

Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy | Bone Marrow Transplantation ⁦@BMTjournal⁩

Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimens ⁦@BMTjournal⁩